These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 2182235)
21. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction. Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW; Norry EC Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577 [TBL] [Abstract][Full Text] [Related]
22. Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection. Marder VJ; Rothbard RL; Fitzpatrick PG; Francis CW Ann Intern Med; 1986 Mar; 104(3):304-10. PubMed ID: 3511819 [TBL] [Abstract][Full Text] [Related]
23. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC). Johnson ES; Cregeen RJ Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612 [TBL] [Abstract][Full Text] [Related]
24. Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study. Monnier P; Sigwart U; Vincent A; Bachmann F; Goy JJ; Schaller MD; Kaufmann U; Badan M; Grbic M; Perret C Drugs; 1987; 33 Suppl 3():175-8. PubMed ID: 3315587 [TBL] [Abstract][Full Text] [Related]
25. [Study of survival using anistreplase (Eminase)]. Murray RG Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():37-40. PubMed ID: 2108645 [TBL] [Abstract][Full Text] [Related]
26. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Kasper W; Meinertz T; Wollschläger H; Bonzel T; Chen C; Hofmann T; Zeiher A; Drexler H; Just H Drugs; 1987; 33 Suppl 3():112-6. PubMed ID: 3315575 [TBL] [Abstract][Full Text] [Related]
27. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. AIMS Trial Study Group. Lancet; 1990 Feb; 335(8687):427-31. PubMed ID: 1968167 [TBL] [Abstract][Full Text] [Related]
28. Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Hogg KJ; Gemmill JD; Burns JM; Lifson WK; Rae AP; Dunn FG; Hillis WS Lancet; 1990 Feb; 335(8684):254-8. PubMed ID: 1967720 [TBL] [Abstract][Full Text] [Related]
29. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group. Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934 [TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent. Anderson JL J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):22B-27B. PubMed ID: 3312369 [TBL] [Abstract][Full Text] [Related]
31. [Bolus injection of anisoylated plasminogen-streptokinase activator complex (BRL 26921) as an alternative concept of systemic lysis in acute myocardial infarct]. Doenecke P; Schwerdt H; Hellstern P; Wenzel E; Bette L Klin Wochenschr; 1986 Aug; 64(15):682-7. PubMed ID: 3531704 [TBL] [Abstract][Full Text] [Related]
32. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction. Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648 [TBL] [Abstract][Full Text] [Related]